INTIENT Unify Cell & Gene

Accelerating and streamlining Cell & Gene Therapy enrollment and coordination across the entire patient journey.

Enabling next-gen therapies

Our unique industry solution connects stakeholders in the Cell & Gene Therapy value chain, enabling manufacturers, supply chain partners and Healthcare Providers (HCPs), to work in a harmonized, standardized way.

Multi-tenant by design, the purposeful architecture of INTIENT Unify Cell & Gene orchestrates patient enrollment, reduces cost and the potential risks of therapy coordination—improving time-to-therapy.

Until now, manufacturers have worked on this problem independently. The multitude of solutions frustrates both access and affordability for HCPs. Teaming with Life Sciences industry leaders, we reimagined and redesigned the interactions between the stakeholders across the Cell & Gene value chain to create a streamlined experience. INTIENT Unify delivers a consistent experience in a secured application.

Advancing Cell & Gene therapies

Advancing Cell & Gene Therapies Dr. Khalid Sha, Harvard Medical School

Advancing Cell & Gene Therapies: Dr. Khalid Shah

Accenture INTENT Summit Video Cell and Gene Therapy Luminary Speaker

View Transcript
Advancing Cell & Gene Therapies panel discussion INTIENT Summit 2022

Industry leads on Advancing Cell & Gene Therapies

Accenture INTENT Summit Video Cell and Gene Therapy Panel

View Transcript

Capabilities

INTIENT drives interaction, not just integration. With our solution, treatment centers for Cell & Gene Therapies interact directly with the manufacturers who are creating the patient-specific treatment. This consistent experience may be deployed for clinical trials and real-world commercial use.

Harmonized, efficient 

Enabling streamlined interactions between healthcare providers and manufacturers, reducing administrative burden, cost, and improving time-to-therapy.

Compliant, secure

GxP and HIPAA compliant, safeguarding the privacy of patient data and manufacturer intellectual property.

Configurable, modular

Configurable for clinical and commercial therapies and modalities. Modular deployment supports developers at different stages in their CGT lifecycle.

View All

Insights from our experts to help pharmaceutical, biotechnology, med-tech, and consumer health companies improve patient outcomes.

The E suite of Ecosystems: E for efficiencies

By harnessing historical clinical trial and real-world data, we are making trials more efficient and ethical through the use of external control arms.

The E suite of Ecosystems: E for efficacious

One of the most exciting areas of innovation is Cell and Gene Therapy, with many therapies already changing the industry and patients’ lives.

The E suite of Ecosystems: Ease of access

How a partner ecosystem can make decentralized clinical trials mainstream.

Our leaders

Subscription Center
Stay in the know with our newsletter Stay in the know with our newsletter